MANUFACTURING PROBLEMS AS OF 12th October 2017
|
|
- Clarence Shelton
- 5 years ago
- Views:
Transcription
1 MANUFACTURING PROBLEMS AS OF 12th October 2017 If you know of any stock Issues that are not on this list please get in touch at Dumfries and Galloway on the date displayed and may not apply to other regions. Drug Manufacturer Brand Name Comments Adalat La 20mg Bayer plc Audavate Rd 0.025% w/w Cream Actavis Out of stock - No Date Suggested Alternatives Date of first reported issue as yet 15/06/2017 Out of stock - Expected April 2018 betnovate RD Cream Alphaderm Cream 30g & 100g Alliance Pharma Out of Stock - No date as yet Alzain 25mg, 75mg & 150mg capsule Dr Reddys Avaxim Injection Sanofi Ambrix Vaccine 1 PFS gsk Amoxil Paed Suspension 20ml GSK Bactroban Cream 15g GSK Out of stock - 25mg expected w/c 18/10/17-75mg expected w/c 28/11/17-150mg expected w/c 11/11/17 All other strengths are available - Axalid is a brand of pregabalin and available from AAH, Alliance & Pheonix 17/07/2017 Out of Stock - Hopefully be back available by end of November /08/2017 Out of stock - Expected Quarter Ointment is available
2 Co - amilofruse 5/40mg tablets Aurobindo Colestyramine sachets x 50 Teva Duac Once Daily Gel 3% 60g GSK Out of stock - In quality Control hopefully released within 2-4 weeks 27/07/2017 Out of stock - Quality Issue - Until July/September 2018 October 2017 Conotrane Cream 100g Leo Pharma Limited stock available Cyclimorph 10mg & 15mg Injection 1ml x 5 Concordia Out of stock - 10mg Expected end of October mg No date as yet Questran Sachets available (formulary choice) Diamox SR 250mg capsules Concordia Out of stock -Expected November / Decewmber 2017 no direct alternative Diloxanide 500mg tablets Concordia Temporary Discontinued - No date as yet to re-instate Dilzem Sr 60mg Cap Teva Out of Stock - Expected January/ March 2018 use other brand Diprosone Cream MSD Out of Stock - 30g expected Mid 12/10/2017 November 2017 Dirosone Lotion MSD Out of Stock - No date as yet 12/10/2017 Ceanel Shampoo 150ml & Alliance Pharma Out of stock - No date as yet 500ml 12/10/2017 Distamine 250mg Tablets Alliance Pharma Discontinued Entresto Novartis Pharma Erythormycin 2% Solution x 50ml New product - Limited Stock - Novartis can make urgent supplies directly to contractors within 24 hours GSK Stiemycin Discontinued 125mg Tablets available
3 Estradot 50microgram Patch Novartis Pharma Long term Manufacturing problem - Novartis can supply for Rx one month at a time after account set up Fucibet Cream 30g Leo Pharma Limited stock available Fucidin Cream 15g & 30g Leo Pharma Limited stock available Evorel 50microgram Patch Alliance Fucidin Ointment 15g & 30g Leo Pharma Engerix B Paed PFS non fixed needle 0.5ml GSK Engerix B Vial 1 & 10 GSK 15g Limited Supply Available - 30g out of stock no date as yet Alliance Intermittent supply - Expected Quarter /08/2017 Intermittent supply - Expected Q /06/2017 Engerix B x 1 PFS NFN GSK Out of Stock - Expected Q /06/2017 Engerix PF Syringe Adult 1 x 10 GSK Out of stock - expected Q dose 16/06/2017 Havrix Monodose PFS 1 & 10'S GSK Out of stock - expected Q /06/2017 Havrix Monodose PFS 1 & 10'S Junior GSK Out of stock - packs of 1 expected Late October packs of 10 expected Q Azargo Eye Drops Alcon Limited stock available - Being managed by Alcon - No date 12/10/2017 Isopto Alkaline eye drop 10ml Alcon Discontinued by supplier 17/07/2017 Hepatyrix 1 & 10's PFS GSK Out of Stock - Expected /08/2017 Isotrex Gel x 30g GSK Discontinued
4 Isotrexin Gel x 30g GSK Out of stock- Expected Quarter Adalat Retard 10mg Tablet Bayer plc Kwells 150microgram Bayer plc Out of stock - Expected end of 300microgram back in stock Locoid Cream 30g & 100g Leo Pharma Limited stock available Maxidex Eye Drops 10ml Alcon Navispare Tablet Amco / Mercury Limited stock available - Being managed by Alcon - No date Temporary Discontinued - Unsure at present if will be manufactured again 5ml Available 17/07/2017 use alternative similar diuretic combination diuretics not recommended in the formulary For mental health switch Orphenadrine 50mg Tablets Teva Teva have Discontinued - to Procyclidine or back up Trihexiphenidyl -Advise do not stop abruptly BD OR TDS as you get Cholinergic rebound Occlusol Wart Solution 10ml Alliance Pharma Out of Stock - Expected Late Pavacol D Alliance Pharma Discontinued- Both 300ml & 600ml Actavis brand is in stock Mirtazepine Orodispersible Concordia Out of stock - No date as yet and supplied to both AAH tablets all strengths & Alliance 12/10/2017
5 Phenindione 50mg Tablet Concordia Discontinued Potassium Chloride 600mg SR Tablets Alliance Pharma Slow K Discontinued by Alliance Pharma Cytotec Tablets x 60's Pfizer Detrusitol 2mg Tablet Pfizer Premarin 1.25mg tablets Pfizer Constella 290microgram Capsule Allergan FML Eye Drops 5ml Allergan Pred Forte eye drops Allergan Out of stock - 10ml will not be available all mg & 25mg are available - check with PST regarding cost?? 17/07/2017 Out of Stock - Expected Monday 16/10/17 12/10/2017 Out of Stock - Expected w/e 20/10/17 12/10/2017 In Quality Control - no date as yet of being released 17/07/2017 Out of Stock - Expected w/c 16/10/17 Out of Stock - Expected December ml available 5ml in stock at present although low stock levels - next order due 11th September 2017 Prednisolone 2.5mg & 5mg ec tablets Alliance Pharma Deltacortril Discontinued by manufacturers - Alliance Pharma do a generic Predniolone ec tablet 2.5mg & 5mg in packs of 30's now - Both in stock Premique tablets 0.625mg/5mg Pfizer Discontinued Prempak-C 0.625mg Pfizer Discontinued both strengths Protopic Ointment 60g Leo Pharma N/A Limited supply available Pneumococcal Vaccine MSD Out of Stock - Expected start of November 2017
6 Provera 10mg x 10 & 100's Pfizer Quinaderm 5% cream x 50g Alliance Pharma N/A Quinaderm 10% cream 25g & 50g Alliance Pharma Out of Stock - Expected early November /10/2017 Raw material problem - Not expecetd untill Mid 2018 Raw material problem - Not expected untill Mid 2018 Respontin Nebules 1ml & 2ml GSK Discontinued Rabies Vaccine BP Sanofi Out of Stock - No date as yet 12/10/2017 Revaxis Injection Sanofi Out of Stock - No date as yet 12/10/2017 Synflorix vaccine 1PFS GSK Out of stock - Expected /06/2017 Teoptic 1% Eye Drops Thea Pharmaceuticals N/A Discontinued 2% still currently Manufactured 01/06/2017 Traxam Pain Relief 3% gel 100g Concordia Out of stock - Technical Issue - non formulary use expected Quarter ibuprofen gel Traxam 3% gel 30g concordia Out of stock - Technical Issue - non formulary use expected Quarter ibuprofen gel Trimovate Cream 30g GSK N/A Out of Stock - Expected Quarter /06/2017 Twinrix PFS 1 & 10'S GSK N/A Expected Quarter Twinrix Paediatric 1 Dose GSK Intermittent supply - Expected Quarter /08/2017 Typherix Vaccine 1 & 10 PFS GSK Out of Stock - Expected /08/2017 Vaqta Adult & Paediatric Out of Stock - Expected start of MSD Injection November /08/2017 Varilrix Vial & Dil GSK N/A Out of stock - Expected Mid October 2017 Viatim Injection Sanofi Out of Stock- Expected end of NoVEMBER 07/08/2017 Zantac Tablets 150mg & 300mg GSK Out of Stock - Expected Quarter Switch to generic Zorac Gel 0.1% Gel Out of Stock - Expected w/c Allergan 16/10/17
7 Viagra 50mg x 4's Pfizer Out of Stock - In Quality control - No date of being released - Pack size 8's available or Generic 12/10/2017
MANUFACTURING PROBLEMS AS OF 31st January 2018
3 MANUFACTURING PROBLEMS AS OF 31st January 2018 If you know of any stock Issues that are not on this list please get in touch at ahope@nhs.net The information contained in this bulletin is based on information
More informationNHS Prescription Services Understanding your Schedule of Payments. For Pharmacy Contractors paid by the NHS Business Services Authority
NHS Prescription Services Understanding your Schedule of Payments For Pharmacy Contractors paid by the NHS Business Services Authority Your payments At the beginning of each month, pharmacy contractors
More informationOur core lies in quality, performance and courage
Our core lies in quality, performance and courage Tabuk Pharmaceuticals develops, manufactures, markets and distributes branded generic pharmaceuticals and under-licensed products globally, with a strong
More informatione f forte.uk.com
t 0370 241 8717 e info@forte.uk.com f 01622 790 754 forte.uk.com April 2016 The announcement in February of the result of negotiations between the GPC and NHS Employers was recognition from government
More informationCoverage Period: 08/16/ /15/2018 Coverage for: Individual and/or Family
This is only a summary of your GatorCare pharmacy benefits. If you would like detail about your coverage and costs, you can get the complete terms in the policy or plan document at gatorcare.magellanpharmacysolutions.com/member
More informationHealthcare Sector The Stock Market SIM, Professor West. Yiping Yang, Lu Yu
Healthcare Sector The Stock Market SIM, Professor West Yiping Yang, Lu Yu 1 Agenda Sector Overview Business and Economic Analysis Financial Analysis Valuation Analysis Recommendation 2 Sector Overview
More informationLimited Tender No.25/RCC/14:15/P2 dated 14 th October 2014
Limited Tender No.25/RCC/14:15/P2 dated 14 th October 2014 Sealed limited tenders are invited in two bid system for the supply of following drugs for Regional Cancer Centre, Trivandrum. The tenders should
More informationCoverage Period: 08/16/ /15/2018 Coverage for: Individual and/or Family Plan: GatorGradCare
This is only a summary of your GatorCare pharmacy benefits. If you would like detail about your coverage and costs, you can get the complete terms in the policy or plan document at gatorcare.magellanrx.com/member
More informationCoverage Period: 01/01/ /31/2019 Coverage for: Individual and/or Family Plan: Healthy Rewards HSA
This is only a summary of your GatorCare pharmacy benefits. If you would like detail about your coverage and costs, you can get the complete terms in the policy or plan document at gatorcare.magellanrx.com/member
More informationSee Important Reminder at the end of this policy for important regulatory and legal information.
Clinical Policy: (Dupixent) Reference Number: CP.PHAR.336 Effective Date: 05.01.17 Last Review Date: 02.18 Line of Business: Commercial, Health Insurance Marketplace, Medicaid Revision Log See Important
More informationYour Medicines Supply Chain toolkit. Your NPA. Equipping you to survive and thrive
Your Medicines Supply Chain toolkit Your NPA Equipping you to survive and thrive Abbott Diabetes 6% 5% 0% + 6% Nutritional ZD ZD 0% Other X X 0% + 6% Abbvie X X 0% Actavis - Warner Chilcott 5.5% 6% X AHA
More informationGlaxoSmithKline Pharmaceuticals Limited Annual Analyst Meet, September 2017
GlaxoSmithKline Pharmaceuticals Limited Annual Analyst Meet, 2017 1 September 2017 GlaxoSmithKline Pharmaceuticals Limited Analyst Update 1 September 2017 A. Vaidheesh, Managing Director Andrew Aristidou,
More informationDrug Price Adjustments under Taiwan s Health Insurance System
Drug Price Adjustments under Taiwan s Health Insurance System Jau-Jie, Huang Senior Executive Officer Division of Medical Review and Pharmaceutical Benefits National Health Insurance Administration, Taiwan
More informationInstitutional Equities
Sector Update Pharmaceutical Sector 1 October 218 Prescription Charts of Interest September 218 Dr. Reddy s Laboratories During the quarter, the company gained strength in Aloxi while it continues to maintain
More informationCoverage Period: Coverage for: Plans: This is only a summary of your GatorCare pharmacy benefits. Coinsurance: you your Dependent Copayment: you
This is only a summary of your GatorCare pharmacy benefits. If you would like detail about your coverage and costs, you can get the complete terms in the policy or plan document at gatorcare.magellanrx.com/member
More informationDepartment of Public Safety and Correctional Services
Department of Public Safety and Correctional Services Office of the Secretary 300 E. JOPPA ROAD SUITE 1000 TOWSON, MARYLAND 21286-3020 (410) 339-5000 FAX (410) 339-5071 TOLL FREE (877) 379-8636 V/TTY (800)
More informationHow to control the rising cost of medicines in Europe
How to control the rising cost of medicines in Europe Dr Andrew Hill Department of Translational Medicine, University of Liverpool, UK Sofia, Bulgaria, March 6 th 2018 How cheaply can medicines be produced?
More informationFor personal use only
MAYNE PHARMA ANNOUNCES ACQUISITION OF US GENERIC PRODUCT PORTFOLIO FROM TEVA AND ALLERGAN NOT FOR DISTRIBUTION OR RELEASE IN THE UNITED STATES 28 June 2016, Adelaide, South Australia Mayne Pharma Group
More information2018 MEDICARE ADVANTAGE FORMULARY CHANGES
2018 MEDICARE ADVANTAGE FORMULARY CHANGES Helpful Questions & Answers TexanPlus HMO, TexanPlus HMO-POS, Today s Options PPO, Today s Options PFFS, and TexanPlus HMO-SNP are Medicare Advantage plans with
More informationInstitutional Presentation. June/2016
V2 Institutional Presentation June/2016 Disclaimer This release contains forward-looking statements that are exclusively related to the prospects of the business, its operating and financial results, and
More informationIMPAX LABORATORIES INC
IMPAX LABORATORIES INC FORM 8-K (Current report filing) Filed 02/20/14 for the Period Ending 02/20/14 Address 30831 HUNTWOOD AVENUE HAYWARD, CA 94544 Telephone 510-240-6000 CIK 0001003642 Symbol IPXL SIC
More informationProf. Claude Farrugia Vice President Communications, EIPG
Prof. Claude Farrugia Vice President Communications, EIPG Is the storm over? Malta, 2008 Is the storm over? Malta, 2008 Is the storm over? Malta, 2008 Drug Development is Risky Drug Development is a Costly
More informationOntario Drug Benefit Formulary/Comparative Drug Index
Ministry of Health and Long-Term Care Ontario Drug Benefit Formulary/Comparative Drug Index Edition 42 Summary of Changes May 2017 Effective May 31, 2017 Drug Programs Policy and Strategy Branch Ontario
More informationPatient Assistance Program PO BOX 66764, St. Louis, MO 63166
The Allergan Patient Assistance Program (PAP) provides Allergan medicines at no cost to eligible patients. If the patient qualifies, twelve-month eligibility for the requested medication(s) or device(s)
More informationGlaxoSmithKline Pharmaceuticals
3QFY2017 Result Update Pharmaceutical February 15, 2017 GlaxoSmithKline Pharmaceuticals Performance Highlights Y/E Mar (` cr) 3QFY2017 2QFY2017 % chg (QoQ) 3QFY2016 % chg (YoY) NEUTRAL CMP `2,683 Target
More informationANTARES PHARMA REPORTS FOURTH QUARTER AND FULL YEAR 2013 OPERATING AND FINANCIAL RESULTS. --OTREXUP Launched To Rheumatologists And Dermatologists--
ANTARES PHARMA REPORTS FOURTH QUARTER AND FULL YEAR 2013 OPERATING AND FINANCIAL RESULTS --OTREXUP Launched To Rheumatologists And Dermatologists-- EWING, NJ, March 13, 2014 -- Antares Pharma, Inc. (NASDAQ:
More informationSee Important Reminder at the end of this policy for important regulatory and legal information.
Clinical Policy: (Eucrisa) Reference Number: CP.PMN.110 Effective Date: 02.21.17 Last Review Date: 05.18 Line of Business: Commercial, Medicaid Revision Log See Important Reminder at the end of this policy
More informationFood supplements as part of the OTC Market
1/16/218 Food supplements as part of the OTC Market Hynek Valerián, IQVIA Copyright 218 IQVIA. All rights reserved. + Global and European context for OTC market Table of Contents + Czech Republic OTC and
More informationTeva Pharmaceutical Industries Ltd. Q May 3, 2018
Teva Pharmaceutical Industries Ltd. Q1 2018 May 3, 2018 Cautionary Note Regarding Forward-Looking Statements This presentation contains forward-looking statements within the meaning of the Private Securities
More informationBackground Distribution and Safety Issues in the United States Consumer Advertising/Promotion World Health and Life Expectancy
CHAPTER ONE: EXECUTIVE SUMMARY Background Scope and Methodology Size and Growth of the Market Key Issues and Trends Affecting Market Leading Competitors CHAPTER TWO: INTRODUCTION Background Distribution
More informationHealth Plan of Marathon Oil Company Prescription Drug Program Choice Plus Traditional Option
Health Plan of Marathon Oil Company Prescription Drug Program Choice Plus Traditional Option This summary plan description constitutes part of the Health Plan of Marathon Oil Company plan document along
More informationMayne Pharma Group Limited
Mayne Pharma Group Limited 1HFY17 Results Presentation 24 February 2017 Scott Richards, Chief Executive Officer Mark Cansdale, Group CFO 1 Disclaimer The information provided is general in nature and is
More informationAnalgesics Non-Seroidal Anti-inflammat
Aspirin Capsules (available in any strength) (30 capsule minimum) 1 mg 3 mg 3. 5 mg Ibuprofen Various Strengths (ask for pricing) Ketoprofen Capsules (available in any strength) 1 mg (100 capsule minimum)
More informationJ.P. Morgan Healthcare Conference
J.P. Morgan Healthcare Conference San Francisco, CA January 10, 2011 Forward Looking Statements Certain statements in this presentation are forward-looking statements within the meaning of Section 21E
More informationAkorn, Inc. N a s d a q : A K R X
Akorn, Inc. N a s d a q : A K R X Jefferies 2014 Global London Healthcare Conference November 2014 DISCLAIMER This presentation includes certain forward-looking statements regarding our views with respect
More informationChanges to Innovation Health Medicare Connection Plan (HMO) and Innovation Health Medicare Voyager Plan (PPO) Formulary
Changes to Innovation Health Medicare Connection Plan (HMO) and Innovation Health Medicare Voyager Plan (PPO) Formulary The table below outlines the changes to our 2018 formulary since the formulary list
More informationPART 14 CORE BUSINESS RULES FOR REIMBURSEMENT SCOTTISH DRUG TARIFF PART 14. CORE BUSINESS RULES FOR REIMBURSEMENT: UPDATED May 1 st 2011
SCOTTISH DRUG TARIFF PART 14 : UPDATED May 1 st 2011 PREFACE The rules as set out below are the basic requirement for reimbursement of items presented on NHS primary care prescription in Scotland. These
More informationQ Earnings Call
We make healthy possible Q3 2018 Earnings Call Financial Results and Business Update November 7, 2018 Safe Harbor Statement & Non-GAAP Financial Measures Safe Harbor Statement Certain statements contained
More informationPharmaceutical Management Commercial Plans
Pharmaceutical Management Commercial Plans 2015 Toll Free Contact Number: (888) 327-0671 Medical Management: (810) 733-9711 Visit our website at: MclarenHealthPlan.org Introduction Pharmaceutical Management
More informationHikma Pharmaceuticals PLC
Hikma Pharmaceuticals PLC This document, which has been issued by Hikma Pharmaceuticals PLC (the Company ), comprises the written materials/slides for a presentation. This document and its contents are
More informationEndo International plc
Endo International plc UBS Healthcare Conference May 23, 2017 Forward Looking Statements; Non-GAAP Financial Measures This presentation contains forward looking statements within the meaning of the Private
More informationStreamlining Practice Processes to Maximise Income for Personally Administered Items
Streamlining Practice Processes to Maximise Income for Personally Administered Items Tracy Hole Ash Lane Consulting Licensed by The Surgery Network 6 th September 2016 Business Platforms Expert support
More informationSeller s Return Goods Policy for Generic Products Unless otherwise required by regulation or law.
Seller s Return Goods Policy for Generic Products Unless otherwise required by regulation or law. The following Return Goods Policy ( Policy ) applies to generic products with the following labeler codes
More informationPrescription Medication Rider
Prescription Medication Rider Rx Member Cost-Sharing: $16/$40/$80/$90 According to this prescription medication program, you may receive coverage for prescription medications in the amounts specified in
More informationChanges to Open 2 Plus (3 Tier) Formulary
Changes to Open 2 Plus (3 Tier) Formulary The table below outlines the changes to our 2018 formulary since the formulary list was last posted to our website on Name of Drug Affected Description of Change
More informationBird s Eye View of Indian Pharma
Bird s Eye View of Indian Pharma Classification of Pharma Industry Pharma industry Formulations Active Pharmaceuticals Ingredients Branded Generics Bulk drugs Pfizer Abbott GSK BMS Teva Mylan Dr Reddy
More informationThe following changes will be effective on April 1, 2018, unless otherwise specified and apply to the following plans:
The following changes will be effective on April 1, 2018, unless otherwise specified and apply to the following plans: Formulary Changes Individual and Family, Large/Small Groups (Commercial) Health Share
More informationSouth Plains Emergency Medical Services, Inc. P.O. Box Lubbock, Texas 79453
South Plains Emergency Medical Services, Inc. P.O. Box 53597 Lubbock, Texas 79453 June 28, 2017 TO: SPEMS EMS Services SUBJECT: SPEMS PARAMEDIC PROTOCOL VARIANCE With the ongoing medication shortages,
More informationAkorn, Inc. Jefferies Healthcare Conference June 9, 2016
Akorn, Inc. Jefferies Healthcare Conference June 9, 2016 Disclaimer This presentation includes statements that may constitute "forward-looking statements", including projections of the impact and allocation
More informationINDOCO REMEDIES LIMITED MANAGEMENT DISCUSSION & ANALYSIS FOR THE SECOND QUARTER FY15. Revenue figures
INDOCO REMEDIES LIMITED MANAGEMENT DISCUSSION & ANALYSIS FOR THE SECOND QUARTER FY15 Revenue figures (` In Lacs) Unaudited Audited Particulars July 14 Sept. 14 Quarter Ended Apr. 14 Jun. 14 July 13 Sept.
More informationCoverage Period: 08/16/ /15/2017 Coverage for: Individual and/or Family
` This is only a summary of your GatorCare pharmacy benefits. If you would like detail about your coverage and costs, you can get the complete terms in the policy or plan document at gatorcare.magellanpharmacysolutions.com/member
More informationCoverage Period: 01/01/ /31/2016 Coverage for: Individual and/or Family
This is only a summary of your GatorCare pharmacy benefits. If you want more detail about your coverage and costs, you can get the complete terms in the policy or plan document at gatorcare.magellanpharmacysolutions.com/member
More informationPrescription Medication Rider
Prescription Medication Rider Rx Member Cost-Sharing: $16/$40/$80/$90 HealthyU HIA/HRA According to this prescription medication program, you may receive coverage for prescription medications in the amounts
More informationEmblem Medicaid 1Q19 Formulary Updates
acetamin-caff-dihydrocod 320.5 Generic with Prior Authorization 1/1/2019 acetaminop-codeine 120-12 mg/5 Generic with Prior Authorization 1/1/2019 acetaminophen-cod #2 tablet Generic with Prior Authorization
More informationGood Practice Guidance 4: Expiry Dates for Medication Adapted from previous NHS Berkshire East guidance, Expiry Date Guidelines for Medication (2010).
Good Practice Guidance 4: Expiry Dates for Medication Adapted from previous NHS Berkshire East guidance, Expiry Date Guidelines for Medication (2010). This guidance is primarily for care home staff but
More informationCase 2:33-av Document Filed 12/22/16 Page 1 of 37 PageID:
Case 2:33-av-00001 Document 28130 Filed 12/22/16 Page 1 of 37 PageID: 816901 James E. Cecchi Lindsey H. Taylor Donald A. Ecklund CARELLA, BYRNE, CECCHI, OLSTEIN, BRODY & AGNELLO, P.C. 5 Becker Farm Road
More informationDynamic Therapeutic Formulary (DTF) A Tiered Drug Plan
Dynamic Therapeutic Formulary (DTF) A Tiered Drug Plan Our tiered DTF drug plan is designed to help you manage drug costs while preserving plan member choice. a two-tiered drug plan. With this approach,
More informationTOTAL MAT 7,99,22, % Unit PTR (Rs.) MAT (Rs.) SKU wise MAT % छ प BRAND. प क व रण Pack Description. क पन Company. Unique No.
Number of Companies consisting of Market Share of 1% & Above 1 Sum of MAT value considered for price calculation (in Lakhs) 799.22 18.4 Spironolactone Tablet 25 mg Per Tablet Sum of PTR per unit considered
More informationASX Announcement MAYNE PHARMA REPORTS RECORD FY14 RESULT
MAYNE PHARMA REPORTS RECORD FY14 RESULT 27 August 2014, Melbourne Australia: Mayne Pharma Group Limited (ASX: MYX) is pleased to release its consolidated results for the year ended 30 June 2014. The Group
More informationPharmaceutical Industry In Pakistan. May 2018
ceutical In Pakistan May 2018 1 Local Players 598 MNC s 27 Total Players 625 Top 50: 89.29% market share Listed companies on PSX: 11 Listed companies: 25.14% market share Market Share Local : MNCs 68 :
More informationSee Important Reminder at the end of this policy for important regulatory and legal information.
Clinical Policy: potassium (Zipsor), (Zorvolex) Reference Number: CP.CPA.280 Effective Date: 11.16.16 Last Review Date: 11.17 Line of Business: Medicaid Medi-Cal Revision Log See Important Reminder at
More informationGuide to The Notification System for Exempt Medicinal Products
Guide to The Notification System for Exempt Medicinal Products AUT-G0090-4 24 MAY 2018 This guide does not purport to be an interpretation of law and/or regulations and is for guidance purposes only. CONTENTS
More informationAnalysis of Maryland s Business Tax Competitiveness. October
Analysis of Maryland s Business Tax Competitiveness October 2010!@# Sponsored by: Maryland Chamber of Commerce Greater Baltimore Committee Hargrove, Inc. Maryland Association of CPAs Technology Council
More information23 rd December Initiating Coverage. Q4 FY17 Earnings Update
23 rd December 2017 Initiating Coverage Q4 FY17 Earnings Update Disclaimer The information contained herein is obtained from sources believed to be reliable. Guiness Securities Ltd is not responsible or
More informationAuthorization and appeals kit: Moderate to severe plaque psoriasis
1 Authorization and appeals kit: Moderate to severe plaque psoriasis Resources for healthcare providers INDICATIONS COSENTYX is indicated for the treatment of moderate to severe plaque psoriasis in adult
More informationCase M TEVA/ALLERGAN GENERICS
EUROPEAN COMMISSION DG Competition Case M. 7746 TEVA/ALLERGAN GENERICS Only the English text is available and authentic. REGULATION (EC) No 139/2004 MERGER PROCEDURE Decision on the implementation of remedies
More informationPharmacy Benefit Management in Oncology
Pharmacy Benefit Management in Oncology October 28 th, 2015 Business Health Care Group Protecting the Future of Oncology Care: A Community Conversation Brent Eberle RPh MBA Chief Pharmacy Officer, Navitus
More informationPharmaceuticals - Generics
Q3: Quarterly Industry Update AS OF September 30, 2017 Pharmaceuticals - Generics INDUSTRY SUMMARY COGENT VALUATION identified Pharmaceuticals - Generics publicly traded companies, IPOs, and recent M&A
More informationN E W S. published. CONTENTS Health Bill CIP Update Manufacturer Quota Schemes
community pharmacy N E W S Briefing Documents for GPs published CONTENTS Health Bill CIP Update Manufacturer Quota Schemes February 2009 PSNCNEWS The end of the ʻNecessary or Expedientʼ Test? The Control
More informationBetter health. Within reach. Every day.
Better health. Within reach. Every day. v Hikma Pharmaceuticals PLC 2018 Interim Results Hikma Pharmaceuticals PLC Group 1H18 financial highlights $989m $214m 21.6% 61.4 $185m Revenue Core 1 operating
More informationEndorsing Guidance for Paper Prescriptions
Endorsing Guidance for Paper Prescriptions Practitioner Services Division and Community Pharmacy Scotland 1 Copyright National Services Scotland / Crown Copyright 2008 First published June 2008 Brief extracts
More informationUNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF NEW YORK ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) )
UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF NEW YORK CHARLES RICHARD HAILE, JR., Individually and On Behalf of All Others Similarly Situated, v. Plaintiff, ALLERGAN PLC, BRENTON L. SAUNDERS, PAUL
More informationTribute Pharmaceuticals Announces Acquisition of Medical Futures Inc., a Canadian Specialty Pharmaceutical Company
June 17, 2015 Tribute Pharmaceuticals Announces Acquisition of Medical Futures Inc., a Canadian Specialty Pharmaceutical Company Includes Canadian Rights to Durela(R), Proferrin(R) and 13 Additional Products
More informationWest Pharmaceutical Services, Inc. June 2016
West Pharmaceutical Services, Inc. June 2016 Safe harbor statement Cautionary Statement Under the Private Securities Litigation Reform Act of 1995 This slide presentation and any accompanying management
More informationNeedyMeds
NeedyMeds www.needymeds.org Find help with the cost of medicine Thank you for downloading this patient assistance document from NeedyMeds. We hope this program will help you get the medicine you need.
More informationSee Important Reminder at the end of this policy for important regulatory and legal information.
Clinical Policy: (Solaraze, Flector) Reference Number: HIM.PA.123 Effective Date: 12.01.17 Last Review Date: 08.18 Line of Business: Health Insurance Marketplace Revision Log See Important Reminder at
More informationCREDIT SUISSE Phoenix, AZ
CREDIT SUISSE Phoenix, AZ November 9-10, 2011 Forward Looking Statements Certain statements in this presentation are forward-looking statements within the meaning of Section 21E of the Securities Exchange
More informationThe Impact of Standards & Pharmacy Informatics
Presented by NCPDP and HIMSS for the Pharmacy Informatics Community The Impact of Standards & Pharmacy Informatics September 20, 2012 Lisa Ashton, Pharm.D. Office of Health Information Integrity, California
More informationAurobindo Pharma Ltd Q1 FY18-19 Financial Results Q1 Q1
NEWS RELEASE 9 th August 2018, Hyderabad, India Consolidated financial results Q1FY18-19 Aurobindo Pharma Ltd Q1 FY18-19 Financial Results Amount in INR Cr Q1 Q1 Q4 FY18-19 FY17-18 FY17-18 Revenue from
More informationLannett Company, Inc. Kremers Urban Acquisition September 2, 2015
Lannett Company, Inc. Kremers Urban Acquisition September 2, 2015 Forward Looking Statements Except for historical facts, the statements in this presentation, as well as oral statements or other written
More informationA Study on comparative Financial Status of selected companies of Indian Pharmaceutical Industry using Efficiency ratios
A Study on comparative Financial Status of selected companies of Indian Pharmaceutical Industry using Efficiency ratios CA. T.A Nikita Ph.D Scholar, GLS University, Ahmedabad, Gujarat ABSTRACT Performance
More informationWhat Can You Do on Monday to Lower Your Supply Cost? Chris Klassen, VP SCA Supply Chain and s4
What Can You Do on Monday to Lower Your Supply Cost? Chris Klassen, VP SCA Supply Chain and s4 1 Discussion Outline 1 2 3 The Fundamentals Cataract Case Study A Manic Monday (and Tuesday) 2 The Fundamentals
More informationCLAIM FORM INSTRUCTIONS
MEDICARE PART D PRESCRIPTION DRUG CLAIM FORM CLAIM FORM INSTRUCTIONS Please read carefully before completing this form. Claim forms that do not include the required information may delay or inhibit our
More information1Q11 & FY10 Financial Results May 11, 2011
1Q11 & FY10 Financial Results May 11, 2011 1 Disclaimer These presentations and discussions contain certain forward looking statements with respect to the results of operation, financial condition and
More informationThe Brazil, Russia, India & China Over-the-Counter Pharmaceuticals Market to 2025 **SAMPLE**
The Brazil, Russia, India & China Over-the-Counter Pharmaceuticals Market to 2025 **SAMPLE** Pharmaceutical, commercial and strategic developments in the Brazil, Russia, India & China Over-the- Counter
More information4. Answer Key for Sample Questions (p 35)
Module Four Prescriptions, Insurance, and Inventory Table of Contents 1. Prescriptions A. Pharmacy Prescription Settings (p 3) i. Community Pharmacy (p 3) ii. Institutional Pharmacy (p 3) iii. All Pharmacy
More informationPOLICY STATEMENT: PROCEDURE:
PAGE 1 OF 12 POLICY STATEMENT: NPS shall provide an automated process to assist beneficiaries who are transitioning from drug regimens or therapies that are not covered on the Part D Plan S are on the
More informationClinical Policy: Naproxen Oral Suspension (Naprosyn) Reference Number: HIM.PA.130 Effective Date: Last Review Date: 11.18
Clinical Policy: (Naprosyn) Reference Number: HIM.PA.130 Effective Date: 12.01.17 Last Review Date: 11.18 Line of Business: HIM Revision Log See Important Reminder at the end of this policy for important
More informationBlue Essentials, Blue Advantage HMO SM and Blue Premier SM Provider Manual - Pharmacy
Blue Essentials, Blue Advantage HMO SM and Blue Premier SM Provider Manual - In this Section there are references unique to Blue Essentials, Blue Advantage HMO and Blue Premier. These network specific
More informationPrescription Item Report Glossary for Pharmacy Contractors
Prescription Item Report Glossary for Pharmacy Contractors A B C D E OCS Code Dispensing Month Fragment Id Form Number Item Number The contractor code (beginning F) allocated by NHSBSA which is a unique
More informationNuQuest/Bridge Pointe
WCMSA Reference Guide; Challenges, Pitfalls and the Industries Response The guide was created to provide a resource to submitters on what documentation is to be provided with the submission and how the
More informationUpcoming changes to your prescription drug coverage Here are important details about upcoming plan changes.
151 Farmington Avenue Hartford, CT 06156 March, 2015 Upcoming changes to your prescription drug coverage Here are important details about upcoming plan changes. The enclosed chart shows changes that start
More informationPrescription Item Report Glossary for Pharmacy Contractors
Prescription Item Report Glossary for Pharmacy Contractors A OCS Code The contractor code (beginning F) allocated by NHSBSA which is a unique identifier for a pharmacy contractor account. B Dispensing
More informationSecond Quarter 2017 Operating and Financial Results Conference Call
Second Quarter 2017 Operating and Financial Results Conference Call August 8, 2017 1 Safe Harbor Statement This presentation contains forward-looking statements within the meaning of the safe harbor provisions
More informationPLAN DESIGN & BENEFITS. $100 Individual/$200 Family $500 Individual/$1000 Family
PLAN FEATURES Deductible (per calendar year) Provider None $1000 Individual/$2000 Family Deductible (per calendar year) Facility Level A: Level B: $100 Individual/$200 Family $500 Individual/$1000 Family
More informationSee Important Reminder at the end of this policy for important regulatory and legal information.
Clinical Policy: (Linzess) Reference Number: CP.PMN.71 Effective Date: 11.01.15 Last Review Date: 02.18 Line of Business: Health Insurance Marketplace, Medicaid Revision Log See Important Reminder at the
More informationClassification: Clinical Department Policy Number: Subject: Medicare Part D General Transition
Classification: Clinical Department Policy Number: 3404.00 Subject: Medicare Part D General Transition Effective Date: 01/01/2019 Process Date Revised: 07/20/2018 Date Reviewed: 05/29/2018 POLICY STATEMENT:
More informationUSES: This medication is used along with a non-drug program (including diet changes) to treat cholesterol and lipid disorders.
Fenofibrate Capsule, Fenofibrate Capsule India, Fenofibrate Capsule manufacturers India, side effects Fenofibrate Capsule manufacturers, Taj Pharma India, Fenofibrate Capsule overdose, Fenofibrate Capsule
More informationTrends in Medicare Part D Benefit Design and Cost Sharing for Adult Vaccines,
FEBRUARY 2018 Trends in Medicare Part D Benefit Design and Cost Sharing for Adult Vaccines, Few Medicare Part D Plans Offer Adult Vaccines Without Cost Sharing Annemarie Wouters, Senior Advisor Sandy W.
More informationH1 Results July 2012
H1 Results 2012 25 July 2012 Andrew Witty Chief Executive Officer Simon Dingemans Chief Financial Officer Continued execution of our strategy in a difficult external environment Grow a diversified global
More information